These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 16189252

  • 1. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M, Norjavaara E, Dunkel L.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Dec; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 3. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L.
    Horm Res; 2009 Nov; 71(5):290-7. PubMed ID: 19339794
    [Abstract] [Full Text] [Related]

  • 7. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel treatment of short stature with aromatase inhibitors.
    Dunkel L, Wickman S.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
    [Abstract] [Full Text] [Related]

  • 10. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
    Papadimitriou DT, Dermitzaki E, Papagianni M, Papaioannou G, Papaevangelou V, Papadimitriou A.
    J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
    [Abstract] [Full Text] [Related]

  • 11. Treatment of delayed male puberty: efficacy of aromatase inhibition.
    Dunkel L, Wickman S.
    J Pediatr Endocrinol Metab; 2001 Apr; 14 Suppl 6():1541-6. PubMed ID: 11837512
    [Abstract] [Full Text] [Related]

  • 12. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
    Wikström AM, Bay K, Hero M, Andersson AM, Dunkel L.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4705-8. PubMed ID: 16926256
    [Abstract] [Full Text] [Related]

  • 13. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
    Shams K, Cameo T, Fennoy I, Hassoun AA, Lerner SE, Aranoff GS, Sopher AB, Yang C, McMahon DJ, Oberfield SE.
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
    [Abstract] [Full Text] [Related]

  • 14. Cognitive effects of aromatase inhibitor therapy in peripubertal boys.
    Hero M, Maury S, Luotoniemi E, Service E, Dunkel L.
    Eur J Endocrinol; 2010 Jul; 163(1):149-55. PubMed ID: 20421333
    [Abstract] [Full Text] [Related]

  • 15. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
    Wickman S, Sipilä I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L.
    Lancet; 2001 Jun 02; 357(9270):1743-8. PubMed ID: 11403810
    [Abstract] [Full Text] [Related]

  • 16. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty].
    Zhao X, Zhang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr 02; 16(4):397-400. PubMed ID: 24750838
    [Abstract] [Full Text] [Related]

  • 17. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J, Damaso L, Merinbaum D, Singh RJ, Gaete X, Mericq V.
    J Clin Endocrinol Metab; 2016 Dec 02; 101(12):4984-4993. PubMed ID: 27710241
    [Abstract] [Full Text] [Related]

  • 18. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec 02; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 19. Novel treatment of delayed male puberty with aromatase inhibitors.
    Dunkel L, Wickman S.
    Horm Res; 2002 Dec 02; 57 Suppl 2():44-52. PubMed ID: 12065927
    [Abstract] [Full Text] [Related]

  • 20. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
    Hero M, Tommiska J, Vaaralahti K, Laitinen EM, Sipilä I, Puhakka L, Dunkel L, Raivio T.
    Fertil Steril; 2012 May 02; 97(5):1242-7. PubMed ID: 22405597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.